BIO-key Demonstrates Security and Power of Identity-Bound Biometrics at 2022 Identity Week America October 4–5
WASHINGTON and WALL, N.J., Oct. 03, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: BKYI) will demonstrate its Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions at the (Booth 345) in Washington, DC, Tuesday and Wednesday, October 4-5. BIO-key has seamlessly integrated the power of Identity-Bound Biometrics into its IAM platform and its multi-factor authentication mobile app, , making it easy to incorporate the security and convenience of biometrics into any IAM strategy.
Stop by booth 345 to discover BIO-key's unique line of hardware and software IAM solutions, including their unified IAM platform PortalGuard that sets itself apart by offering Identity-Bound Biometrics, one of many supported methods for its multi-factor authentication (MFA), single sign-on, and self-service password reset capabilities. IBB’s inherent security and flexibility make it ideal for authenticating identities in password-less, phone-less, token-less, remote work, and zero trust environments, and for users who roam among shared workstations or kiosks (such as in retail, healthcare, manufacturing, and contact centers).
Jim Sullivan, an expert in IAM and biometrics and BIO-key’s SVP of Strategy and Compliance and Chief Legal Officer, will be featured in multiple sessions on . Jim will host a Seminar Theater session on the topic, “Overcoming an unholy trio of anti-biometric adversaries,” October 4th at 4:20 p.m., discussing how privacy experts, device manufacturers, and even fraudsters are delaying the adoption of biometrics for all the wrong reasons. Jim will also host a roundtable discussion “,” October 5th at 12:10 p.m.
Formerly known as Connect ID, Identity Week is one of the most important identity and authentication events in the United States, focusing this year on the importance of identity and trust in our 'new normal' world.
“Identity Week provides an ideal, expanded platform to highlight the unique ability of our Identity-Bound Biometrics to establish trust between people completing digital transactions,” said Michael DePasquale, Chairman and CEO of BIO-key. “This year is particularly exciting for BIO-key given the event’s expanded focus on how we can reimagine digital identity.”
BIO-key will showcase FacePositive™, the newest IBB-powered modality for its MobileAuth MFA mobile app, which uses facial recognition to verify the person requesting access, and builds on PalmPositive™, the app’s palm scanning authentication method. MobileAuth also now supports device-based biometric authentication methods including Apple Face ID, Touch ID, and Android Biometrics, as well as push token authentication support. These enhancements make biometrics even easier to deploy across a broader set of use cases and allow customers to further consolidate their authentication and security needs into one solution.
BIO-key will also demonstrate its hardware devices:
- : BIO-key’s Microsoft-qualified Windows Hello USB scanners that can be used out of the box with Windows Hello and Windows Hello for Business or in conjunction with BIO-key’s Identity Bound Biometrics:
- FBI-certified Mobile ID FAP 50 and Live Scan (10-Print) Pocket10™ for verification capture in 4-4-2 format.
- PIV-Pro FIPS-201 compliant scanner
- EcoID™ II scanner
- SidePass Compact USB-A or -C scanner
- SideSwipe Compact USB-A scanner
- : BIO-key offers an affordably priced FIDO2 security key lineup, with USB-A, USB-C, NFC, and iOS Lightning compatibility along with FIPS 140-2 certified options with on-device biometric verification.
- All-in-One POS Terminal: BIO-key’s is a handheld, all-in-one, smart Point of Sale (POS) machine, with a built-in FBI-certified fingerprint module for biometric identification and verification. Developed for the payment industry, MobilePOS also suits diverse user scenarios, such as microfinance, SIM registration, inventory management, and more.
For more information on Identity Week America 2022, . To learn more about BIO-key’s IAM and IBB solutions, .
About BIO-key International, Inc. ()
BIO-key has over two decades of expertise in providing authentication technology for thousands of organizations and millions of users and is revolutionizing authentication with biometric-centric, multi-factor identity and access management (IAM) solutions, including its PortalGuard IAM solution, that provides convenient and secure access to devices, information, applications, and high-value transactions. BIO-key's patented software and hardware solutions, with industry-leading biometric capabilities, enable large-scale on-premises and cloud-based Identity-as-a-Service (IDaaS) solutions, as well as customized enterprise solutions.
BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; the duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, personnel, and the geographic markets in which we operate; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption see "Risk Factors'' in our Annual Report on Form 10-K for the year ended December 31, 2021 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Additionally, there may be other factors of which the Company is not currently aware that may affect matters discussed in forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the coronavirus outbreak to economic conditions and the industry in general and the financial position and operating results of our Company, in particular, have been material, are changing rapidly, and cannot be predicted.
Engage with BIO-key
Facebook – Corporate:
LinkedIn – Corporate:
Twitter – Corporate:
Twitter – Investors:
StockTwits:
Media Contact
Erin Knapp
Matter on behalf of BIO-key
Investor Contacts
William Jones, David Collins
Catalyst IR
212-924-9800
